{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T09:21:01Z","timestamp":1724577661317},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,10,7]],"date-time":"2012-10-07T00:00:00Z","timestamp":1349568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12185-012-1193-8","type":"journal-article","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T08:53:16Z","timestamp":1349513596000},"page":"810-813","source":"Crossref","is-referenced-by-count":3,"title":["Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea"],"prefix":"10.1007","volume":"96","author":[{"given":"Vikas","family":"Dua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satya Prakash","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupam","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,7]]},"reference":[{"issue":"3","key":"1193_CR1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2007-1000654","volume":"21","author":"AH Sutor","year":"1995","unstructured":"Sutor AH. Thrombocytosis in childhood. Semin Thromb Hemost. 1995;21(3):330\u20139.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"1193_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/adc.2006.111484","volume":"92","author":"A Denton","year":"2007","unstructured":"Denton A, Davis P. Extreme thrombocytosis in admissions to paediatric intensive care: no requirement for treatment. Arch Dis Child. 2007;92(6):515\u20136.","journal-title":"Arch Dis Child"},{"key":"1193_CR3","doi-asserted-by":"crossref","unstructured":"Yohannan MD, Higgy KE, al-Mashhadani SA, Santhosh-Kumar CR. Thrombocytosis. Etiologic analysis of 663 patients. Clin Pediatr (Phila).1994;33(6):340\u20133.","DOI":"10.1177\/000992289403300605"},{"issue":"12","key":"1193_CR4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1440-1754.2005.00757.x","volume":"41","author":"N Othman","year":"2005","unstructured":"Othman N, Isaacs D, Kesson A. Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health. 2005;41(12):671\u20136.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"1193_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2710.1993.tb00565.x","volume":"18","author":"JL Frye","year":"1993","unstructured":"Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther. 1993;18(1):45\u20138.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"1193_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1054\/blre.2001.0162","volume":"15","author":"AI Schafer","year":"2001","unstructured":"Schafer AI. Thrombocytosis and thrombocythemia. Blood Rev. 2001;15(4):159\u201366.","journal-title":"Blood Rev"},{"key":"1193_CR7","unstructured":"El-Harith el-HA, Roesl C, Ballmaier M, Germeshausen M, Frye-Boukhriss H, von Neuhoff N, et al. Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene. Br J Haematol. 2009;144(2):185\u201394."},{"issue":"2","key":"1193_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood-2007-12-128454","volume":"112","author":"JL Spivak","year":"2008","unstructured":"Spivak JL, Silver RT. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood. 2008;112(2):231\u20139.","journal-title":"Blood"},{"issue":"5","key":"1193_CR9","first-page":"309","volume":"40","author":"HL Chen","year":"1999","unstructured":"Chen HL, Chiou SS, Sheen JM, Jang RC, Lu CC, Chang TT. Thrombocytosis in children at one medical center of southern Taiwan. Acta Paediatr Taiwan. 1999;40(5):309\u201313.","journal-title":"Acta Paediatr Taiwan."},{"issue":"4","key":"1193_CR10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2141.1999.01545.x","volume":"107","author":"Y Dror","year":"1999","unstructured":"Dror Y, Blanchette VS. Essential thrombocythaemia in children. Br J Haematol. 1999;107(4):691\u20138.","journal-title":"Br J Haematol"},{"issue":"3","key":"1193_CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2141.2000.02239-7.x","volume":"110","author":"H Hasle","year":"2000","unstructured":"Hasle H. Incidence of essential thrombocythaemia in children. Br J Haematol. 2000;110(3):751.","journal-title":"Br J Haematol"},{"issue":"10","key":"1193_CR12","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood-2006-04-014746","volume":"108","author":"ML Randi","year":"2006","unstructured":"Randi ML, Putti MC, Scapin M, Pacquola E, Tucci F, Micalizzi C, et al. Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative. Blood. 2006;108(10):3600\u20132.","journal-title":"Blood"},{"issue":"6","key":"1193_CR13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/pbc.21730","volume":"51","author":"T Nakatani","year":"2008","unstructured":"Nakatani T, Imamura T, Ishida H, Wakaizumi K, Yamamoto T, Otabe O, et al. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia. Pediatr Blood Cancer. 2008;51(6):802\u20135.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1193_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0609.2009.01246.x","volume":"83","author":"N Gangat","year":"2009","unstructured":"Gangat N, Tefferi A, Thanarajasingam G, Patnaik M, Schwager S, Ketterling R, et al. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance. Eur J Haematol. 2009;83(1):17\u201321.","journal-title":"Eur J Haematol"},{"issue":"Suppl 2","key":"1193_CR15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF03165140","volume":"76","author":"T Barbui","year":"2002","unstructured":"Barbui T. What is the standard treatment in essential thrombocythemia. Int J Hematol. 2002;76(Suppl 2):311\u20137.","journal-title":"Int J Hematol"},{"issue":"5","key":"1193_CR16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/14656566.5.5.1009","volume":"5","author":"ML Randi","year":"2004","unstructured":"Randi ML, Putti MC. Essential thrombocythaemia in children: is a treatment needed? Expert Opin Pharmacother. 2004;5(5):1009\u201314.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"1193_CR17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3324\/haematol.12604","volume":"93","author":"R Landolfi","year":"2008","unstructured":"Landolfi R, Di Gennaro L. Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica. 2008;93(3):331\u20135.","journal-title":"Haematologica"},{"issue":"3","key":"1193_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-3476(95)70090-0","volume":"127","author":"MM Chintagumpala","year":"1995","unstructured":"Chintagumpala MM, Kennedy LL, Steuber CP. Treatment of essential thrombocythemia with anagrelide. J Pediatr. 1995;127(3):495\u20138.","journal-title":"J Pediatr"},{"issue":"17","key":"1193_CR19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","volume":"332","author":"S Cortelazzo","year":"1995","unstructured":"Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med. 1995;332(17):1132\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"1193_CR20","first-page":"1550","volume":"94","author":"TR Kinney","year":"1999","unstructured":"Kinney TR, Helms RW, O\u2019Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial Pediatric Hydroxyurea Group. Blood. 1999;94(5):1550\u20134.","journal-title":"Blood"},{"issue":"11","key":"1193_CR21","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V95.11.3589","volume":"95","author":"VN Heft","year":"2000","unstructured":"Heft VN, Fruchtman SR, Pickens CV, Rosse WF, Howard TA, Ware RE. Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood. 2000;95(11):3589\u201393.","journal-title":"Blood"},{"issue":"4","key":"1193_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.10427","volume":"74","author":"WH Schultz","year":"2003","unstructured":"Schultz WH, Ware RE. Malignancy in sickle cell disease. Am J Hematol. 2003;74(4):249\u201353.","journal-title":"Am J Hematol"},{"issue":"4","key":"1193_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1179\/102453308X316022","volume":"13","author":"F Radaelli","year":"2008","unstructured":"Radaelli F, Onida F, Rossi FG, Zilioli VR, Colombi M, Usardi P, et al. Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. Hematology. 2008;13(4):195\u2013202.","journal-title":"Hematology."},{"issue":"4","key":"1193_CR24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF02982131","volume":"75","author":"D Mavrogianni","year":"2002","unstructured":"Mavrogianni D, Viniou N, Michali E, Terpos E, Meletis J, Vaiopoulos G, et al. Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients. Int J Hematol. 2002;75(4):394\u2013400.","journal-title":"Int J Hematol"},{"issue":"17","key":"1193_CR25","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2011.34.7542","volume":"29","author":"M Bj\u00f6rkholm","year":"2011","unstructured":"Bj\u00f6rkholm M, Derolf AR, Hultcrantz M, Kristinsson SY, Ekstrand C, Goldin LR, et al. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms. J Clin Oncol. 2011;29(17):2410\u20135.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1193_CR26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12185-010-0502-3","volume":"91","author":"S Mizutani","year":"2010","unstructured":"Mizutani S, Kuroda J, Shimizu D, Horiike S, Taniwaki M. Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia. Int J Hematol. 2010;91(3):516\u201321.","journal-title":"Int J Hematol"},{"key":"1193_CR27","unstructured":"Mialou V. Essential thrombocythemia in childhood: the French experience. Pediatr Blood cancer (SIOP abstract). 2005;45:PU005."},{"issue":"1","key":"1193_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pbc.21128","volume":"49","author":"AA El-Moneim","year":"2007","unstructured":"El-Moneim AA, Kratz CP, B\u00f6ll S, Rister M, Pahl HL, Niemeyer CM. Essential versus reactive thrombocythemia in children: retrospective analyses of 12 cases. Pediatr Blood Cancer. 2007;49(1):52\u20135.","journal-title":"Pediatr Blood Cancer"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1193-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1193-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1193-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T14:21:47Z","timestamp":1594736507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1193-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,7]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1193-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,7]]}}}